• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The quality-of-life burden of knee osteoarthritis in New Zealand adults: A model-based evaluation.新西兰成年人膝骨关节炎的生活质量负担:基于模型的评估
PLoS One. 2017 Oct 24;12(10):e0185676. doi: 10.1371/journal.pone.0185676. eCollection 2017.
2
Development and validation of a new population-based simulation model of osteoarthritis in New Zealand.开发并验证新西兰基于人群的骨关节炎新仿真模型。
Osteoarthritis Cartilage. 2018 Apr;26(4):531-539. doi: 10.1016/j.joca.2018.01.004. Epub 2018 Jan 10.
3
Colorectal Cancer Screening: How Health Gains and Cost-Effectiveness Vary by Ethnic Group, the Impact on Health Inequalities, and the Optimal Age Range to Screen.结直肠癌筛查:按族裔群体的差异,看健康收益和成本效益如何变化,对健康不平等的影响,以及筛查的最佳年龄范围。
Cancer Epidemiol Biomarkers Prev. 2017 Sep;26(9):1391-1400. doi: 10.1158/1055-9965.EPI-17-0150. Epub 2017 Jun 16.
4
Mortality trends in Australian Aboriginal peoples and New Zealand Māori.澳大利亚原住民和新西兰毛利人的死亡率趋势。
Popul Health Metr. 2017 Jul 4;15:25. doi: 10.1186/s12963-017-0140-6. eCollection 2017.
5
Impact of low-dose CT screening for lung cancer on ethnic health inequities in New Zealand: a cost-effectiveness analysis.肺癌低剂量 CT 筛查对新西兰族裔健康不平等的影响:成本效益分析。
BMJ Open. 2020 Sep 24;10(9):e037145. doi: 10.1136/bmjopen-2020-037145.
6
Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.比较三种欧洲国家用 EQ-5D 衡量的人口健康状况的不同评估方法。
Value Health. 2009 Jul-Aug;12(5):750-8. doi: 10.1111/j.1524-4733.2009.00509.x.
7
The projected burden of knee osteoarthritis in New Zealand: healthcare expenditure and total joint replacement provision.新西兰膝关节骨关节炎的预计负担:医疗保健支出与全关节置换供应情况
N Z Med J. 2019 Oct 4;132(1503):53-65.
8
Impact of obesity and knee osteoarthritis on morbidity and mortality in older Americans.肥胖和膝骨关节炎对美国老年人发病率和死亡率的影响。
Ann Intern Med. 2011 Feb 15;154(4):217-26. doi: 10.7326/0003-4819-154-4-201102150-00001.
9
The health gains and cost savings of dietary salt reduction interventions, with equity and age distributional aspects.减少膳食盐摄入干预措施在健康收益、成本节约以及公平性和年龄分布方面的情况。
BMC Public Health. 2016 May 23;16:423. doi: 10.1186/s12889-016-3102-1.
10
Manual therapy, exercise therapy, or both, in addition to usual care, for osteoarthritis of the hip or knee. 2: economic evaluation alongside a randomized controlled trial.在常规治疗的基础上,联合使用手法治疗、运动疗法或两者,用于髋或膝关节骨关节炎:一项随机对照试验的经济学评价。
Osteoarthritis Cartilage. 2013 Oct;21(10):1504-13. doi: 10.1016/j.joca.2013.06.014. Epub 2013 Jun 27.

引用本文的文献

1
Assessing knee joint biomechanics and trunk posture according to medial osteoarthritis severity.根据内侧骨关节炎严重程度评估膝关节生物力学和躯干姿势。
Sci Rep. 2023 Nov 6;13(1):19186. doi: 10.1038/s41598-023-46486-1.
2
The cost-effectiveness of recommended adjunctive interventions for knee osteoarthritis: Results from a computer simulation model.膝关节骨关节炎推荐辅助干预措施的成本效益:计算机模拟模型的结果
Osteoarthr Cartil Open. 2020 Nov 19;2(4):100123. doi: 10.1016/j.ocarto.2020.100123. eCollection 2020 Dec.
3
Consensus Guidelines on Interventional Therapies for Knee Pain (STEP Guidelines) from the American Society of Pain and Neuroscience.美国疼痛与神经科学学会发布的《膝关节疼痛介入治疗共识指南》(STEP指南)
J Pain Res. 2022 Sep 8;15:2683-2745. doi: 10.2147/JPR.S370469. eCollection 2022.
4
Source localized infraslow neurofeedback training in people with chronic painful knee osteoarthritis: A randomized, double-blind, sham-controlled feasibility clinical trial.慢性疼痛性膝骨关节炎患者的源定位低频神经反馈训练:一项随机、双盲、假对照可行性临床试验。
Front Neurosci. 2022 Jul 28;16:899772. doi: 10.3389/fnins.2022.899772. eCollection 2022.
5
Long intergenic non-protein coding RNA 00707 regulates chondrocyte apoptosis and proliferation in osteoarthritis by serving as a sponge for microRNA-199-3p.长链非编码 RNA 00707 通过作为 microRNA-199-3p 的海绵调控骨关节炎中软骨细胞的凋亡和增殖。
Bioengineered. 2022 Apr;13(4):11137-11145. doi: 10.1080/21655979.2022.2061287.
6
The impact of novel anchored barbed suture for capsular closure on hospital length of stay after total knee arthroplasty: a retrospective cohort study.新型带倒刺锚钉缝线在全膝关节置换术后囊关闭对住院时间的影响:一项回顾性队列研究。
BMC Musculoskelet Disord. 2022 Apr 11;23(1):349. doi: 10.1186/s12891-022-05292-y.
7
A comparison of three strategies to reduce the burden of osteoarthritis: A population-based microsimulation study.三种减轻骨关节炎负担策略的比较:基于人群的微观模拟研究。
PLoS One. 2021 Dec 8;16(12):e0261017. doi: 10.1371/journal.pone.0261017. eCollection 2021.
8
Proprioceptive Training for Knee Osteoarthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.膝关节骨关节炎的本体感觉训练:随机对照试验的系统评价和荟萃分析
Front Med (Lausanne). 2021 Oct 28;8:699921. doi: 10.3389/fmed.2021.699921. eCollection 2021.
9
Poly beta amino ester coated emulsions of NSAIDs for cartilage treatment.用于软骨治疗的 NSAIDs 的聚β氨基酯包被乳液。
J Mater Chem B. 2021 Jul 28;9(29):5837-5847. doi: 10.1039/d1tb01024g.
10
What Does the Future Hold? Health-Related Quality of Life 3-12 Years Following a Youth Sport-Related Knee Injury.未来如何?青少年运动相关性膝关节损伤后 3-12 年的健康相关生活质量。
Int J Environ Res Public Health. 2021 Jun 26;18(13):6877. doi: 10.3390/ijerph18136877.

本文引用的文献

1
Model-based evaluation of cost-effectiveness of nerve growth factor inhibitors in knee osteoarthritis: impact of drug cost, toxicity, and means of administration.基于模型评估神经生长因子抑制剂治疗膝骨关节炎的成本效益:药物成本、毒性及给药方式的影响
Osteoarthritis Cartilage. 2016 May;24(5):776-85. doi: 10.1016/j.joca.2015.12.011. Epub 2015 Dec 31.
2
Cost-effectiveness of nonsteroidal anti-inflammatory drugs and opioids in the treatment of knee osteoarthritis in older patients with multiple comorbidities.非甾体抗炎药和阿片类药物治疗合并多种疾病的老年患者膝骨关节炎的成本效益
Osteoarthritis Cartilage. 2016 Mar;24(3):409-18. doi: 10.1016/j.joca.2015.10.006. Epub 2015 Oct 23.
3
Longitudinal Course of Physical Function in People With Symptomatic Knee Osteoarthritis: Data From the Multicenter Osteoarthritis Study and the Osteoarthritis Initiative.有症状的膝关节骨关节炎患者身体功能的纵向病程:来自多中心骨关节炎研究和骨关节炎倡议的数据。
Arthritis Care Res (Hoboken). 2016 Mar;68(3):325-31. doi: 10.1002/acr.22674.
4
Current trends and projections in the utilisation rates of hip and knee replacement in New Zealand from 2001 to 2026.2001年至2026年新西兰髋关节和膝关节置换使用率的当前趋势及预测。
N Z Med J. 2014 Aug 29;127(1401):82-93.
5
Lifetime medical costs of knee osteoarthritis management in the United States: impact of extending indications for total knee arthroplasty.美国膝关节骨关节炎管理的终身医疗费用:扩大全膝关节置换术适应证的影响。
Arthritis Care Res (Hoboken). 2015 Feb;67(2):203-15. doi: 10.1002/acr.22412.
6
The individual and socioeconomic impact of osteoarthritis.骨关节炎的个体和社会经济学影响。
Nat Rev Rheumatol. 2014 Jul;10(7):437-41. doi: 10.1038/nrrheum.2014.44. Epub 2014 Mar 25.
7
The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study.全球髋和膝关节骨关节炎负担:来自 2010 年全球疾病负担研究的估计。
Ann Rheum Dis. 2014 Jul;73(7):1323-30. doi: 10.1136/annrheumdis-2013-204763. Epub 2014 Feb 19.
8
Pharmacologic regimens for knee osteoarthritis prevention: can they be cost-effective?预防膝关节骨关节炎的药物治疗方案:它们具有成本效益吗?
Osteoarthritis Cartilage. 2014 Mar;22(3):415-30. doi: 10.1016/j.joca.2014.01.005. Epub 2014 Jan 31.
9
Defining and mapping the person with osteoarthritis for population studies and public health.定义和描绘骨关节炎患者,用于人群研究和公共卫生。
Rheumatology (Oxford). 2014 Feb;53(2):338-45. doi: 10.1093/rheumatology/ket346. Epub 2013 Oct 29.
10
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.291 种疾病和伤害导致的伤残调整生命年(DALYs)在 21 个地区,1990-2010 年:全球疾病负担研究 2010 的系统分析。
Lancet. 2012 Dec 15;380(9859):2197-223. doi: 10.1016/S0140-6736(12)61689-4.

新西兰成年人膝骨关节炎的生活质量负担:基于模型的评估

The quality-of-life burden of knee osteoarthritis in New Zealand adults: A model-based evaluation.

作者信息

Abbott J Haxby, Usiskin Ilana M, Wilson Ross, Hansen Paul, Losina Elena

机构信息

Centre for Musculoskeletal Outcomes Research, Department of Surgical Sciences, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.

Orthopaedic and Arthritis Center for Outcomes Research, Department of Orthopaedic Surgery, Brigham and Women's Hospital, Boston, MA, United States of America.

出版信息

PLoS One. 2017 Oct 24;12(10):e0185676. doi: 10.1371/journal.pone.0185676. eCollection 2017.

DOI:10.1371/journal.pone.0185676
PMID:29065119
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5655469/
Abstract

BACKGROUND

Knee osteoarthritis is a leading global cause of health-related quality of life loss. The aim of this project was to quantify health losses arising from knee osteoarthritis in New Zealand (NZ) in terms of quality-adjusted life years (QALYs) lost.

METHODS

The Osteoarthritis Policy Model (OAPol), a validated Monte Carlo computer simulation model, was used to estimate QALYs lost due to knee osteoarthritis in the NZ adult population aged 40-84 over their lifetimes from the base year of 2006 until death. Data were from the NZ Health Survey, NZ Burden of Diseases, NZ Census, and relevant literature. QALYs were derived from NZ EQ-5D value set 2. Sensitivity to health state valuation, disease and pain prevalence were assessed in secondary analyses.

RESULTS

Based on NZ EQ-5D health state valuations, mean health losses due to knee osteoarthritis over people's lifetimes in NZ are 3.44 QALYs per person, corresponding to 467,240 QALYs across the adult population. Average estimated per person QALY losses are higher for non-Māori females (3.55) than Māori females (3.38), and higher for non-Māori males (3.34) than Māori males (2.60). The proportion of QALYs lost out of the total quality-adjusted life expectancy for those without knee osteoarthritis is similar across all subgroups, ranging from 20 to 23 percent.

CONCLUSIONS

At both the individual and population levels, knee osteoarthritis is responsible for large lifetime QALY losses. QALY losses are higher for females than males due to greater prevalence of knee osteoarthritis and higher life expectancy, and lower for Māori than non-Māori due to lower life expectancy. Large health gains are potentially realisable from public health and policy measures aimed at decreasing incidence, progression, pain, and disability of osteoarthritis.

摘要

背景

膝关节骨关节炎是导致全球与健康相关的生活质量下降的主要原因。本项目的目的是根据损失的质量调整生命年(QALY)来量化新西兰(NZ)膝关节骨关节炎所造成的健康损失。

方法

采用经过验证的蒙特卡洛计算机模拟模型——骨关节炎政策模型(OAPol),来估计2006年基准年至死亡期间,新西兰40 - 84岁成年人群因膝关节骨关节炎在其一生中损失的QALY。数据来源于新西兰健康调查、新西兰疾病负担、新西兰人口普查以及相关文献。QALY源自新西兰EQ - 5D价值集2。在二次分析中评估了对健康状态估值、疾病和疼痛患病率的敏感性。

结果

根据新西兰EQ - 5D健康状态估值,新西兰人群一生中因膝关节骨关节炎导致的平均健康损失为每人3.44个QALY,成年人群总计467,240个QALY。非毛利女性的人均QALY损失估计值(3.55)高于毛利女性(3.38),非毛利男性(3.34)高于毛利男性(2.60)。在所有亚组中,无膝关节骨关节炎者的总质量调整预期寿命中损失的QALY比例相似,范围在20%至23%之间。

结论

在个体和人群层面,膝关节骨关节炎都会导致大量的终生QALY损失。由于膝关节骨关节炎患病率较高和预期寿命较长,女性的QALY损失高于男性;由于预期寿命较低,毛利人的QALY损失低于非毛利人。旨在降低骨关节炎发病率、进展、疼痛和残疾程度的公共卫生和政策措施有可能带来巨大的健康收益。